Lupus cutáneo inducido por adalimumab

Manuela T. Tobón; Juan M. Gutiérrez; Isabel Cuellar; Daniel G. Fernández-Ávila; María C. Díaz

doi:10.1016/j.rcreu.2016.10.001

Lupus cutáneo inducido por adalimumab

Manuela T. Tobón, Juan M. Gutiérrez, Isabel Cuellar, Daniel G. Fernández-Ávila, María C. Díaz

Producción: Contribución a una revista › Artículo › revisión exhaustiva

Resumen

Tumor necrosis factor inhibitors have become one of the most important treatments of rheumatoid arthritis. Adalimumab is a monoclonal antibody used for the treatment of this condition. A case is described of adalimumab induced cutaneous lupus.

Título traducido de la contribución	Adalimumab-induced cutaneous lupus
Idioma original	Español
Páginas (desde-hasta)	271-274
Número de páginas	4
Publicación	Revista Colombiana de Reumatologia
Volumen	23
N.º	4
DOI	https://doi.org/10.1016/j.rcreu.2016.10.001
Estado	Publicada - 01 oct. 2016
Publicado de forma externa	Sí

Palabras clave

Adalimumab
Cutaneous lupus erythematosus
Rheumatoid arthritis

Acceder al documento

10.1016/j.rcreu.2016.10.001

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{7d745d2d781c4927b8ce6570769eb974,

title = "Lupus cut{\'a}neo inducido por adalimumab",

abstract = "Tumor necrosis factor inhibitors have become one of the most important treatments of rheumatoid arthritis. Adalimumab is a monoclonal antibody used for the treatment of this condition. A case is described of adalimumab induced cutaneous lupus.",

keywords = "Adalimumab, Cutaneous lupus erythematosus, Rheumatoid arthritis",

author = "Tob{\'o}n, {Manuela T.} and Guti{\'e}rrez, {Juan M.} and Isabel Cuellar and Fern{\'a}ndez-{\'A}vila, {Daniel G.} and D{\'i}az, {Mar{\'i}a C.}",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.rcreu.2016.10.001",

language = "Espa{\~n}ol ",

volume = "23",

pages = "271--274",

journal = "Revista Colombiana de Reumatologia",

issn = "0121-8123",

publisher = "Asociacion Colombiana de Reumatologia",

number = "4",

}

TY - JOUR

T1 - Lupus cutáneo inducido por adalimumab

AU - Tobón, Manuela T.

AU - Gutiérrez, Juan M.

AU - Cuellar, Isabel

AU - Fernández-Ávila, Daniel G.

AU - Díaz, María C.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Tumor necrosis factor inhibitors have become one of the most important treatments of rheumatoid arthritis. Adalimumab is a monoclonal antibody used for the treatment of this condition. A case is described of adalimumab induced cutaneous lupus.

AB - Tumor necrosis factor inhibitors have become one of the most important treatments of rheumatoid arthritis. Adalimumab is a monoclonal antibody used for the treatment of this condition. A case is described of adalimumab induced cutaneous lupus.

KW - Adalimumab

KW - Cutaneous lupus erythematosus

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85025712236&partnerID=8YFLogxK

U2 - 10.1016/j.rcreu.2016.10.001

DO - 10.1016/j.rcreu.2016.10.001

M3 - Artículo

AN - SCOPUS:85025712236

SN - 0121-8123

VL - 23

SP - 271

EP - 274

JO - Revista Colombiana de Reumatologia

JF - Revista Colombiana de Reumatologia

IS - 4

ER -

Lupus cutáneo inducido por adalimumab

Resumen

Palabras clave

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto